The NIM Vital device is a nerve monitoring system to help physicians identify, confirm and watch nerve function to reduce the risk of nerve damage during head and neck surgery, the release said.
Through the acquisition, Medtronic will add Ai Biomed’s PTeye parathyroid detection system, the release said. The device is designed to help confirm parathyroid tissue during thyroid surgery.
“The addition of these two technologies builds on our 20-year legacy of providing innovative solutions that assist surgeons during critical head and neck procedures,” Vince Racano, vice president and general manager of the ENT business at Medtronic, said in a statement. “By offering these complementary technologies — the NIM Vital system to protect crucial nerves and the PTeye system to help confirm parathyroid tissue identified visually by the surgeon — we’re helping physicians address two of the most common challenges during these procedures.”
Read the full press release here.
More articles on surgery centers:
5 employees of U of New Mexico outpatient surgery center test positive for COVID-19
ASC leaders on top priorities during COVID-19 pandemic
ASCs projected to take 68% of orthopedic surgeries by mid-decade — 5 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.